KCNJ11 and Parkinson disease: Our current set of data corroborate that the expression of kir6.2 in astrocytes under LPS-induced PD pathological conditions is involved in the formation of neurotoxic astrocyte phenotype, which promotes a better understanding of kir6.2’s roles in astrocytic pathology.